AXIOS September 11, 2023
Jason Millman

The Food and Drug Administration approved updated versions of COVID-19 vaccines on Monday, a key step in getting the new shots to Americans as early as this week.

Why it matters: The Biden administration has faced increasing calls to make the reformulated vaccines available more quickly as infections and hospitalizations ticked up in recent weeks.

  • Health officials have largely urged people concerned about protecting themselves against the late-summer surge to wait until the new boosters are available.

Driving the news: The FDA greenlit shots from Pfizer and Moderna that are targeted against the XBB.1.5 variant, which was the dominant strain circulating in the United States earlier this summer.

  • Scientists believe that the shots will be protective against...

Today's Sponsors

LEK
Upfront Healthcare

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
FDA publishes proposal to increase regulatory oversight of lab-developed tests
Everything you need to know about artificial wombs
Listen: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech’s slump
FDA’s IT Strategy: Unlocking Potential, Leading Transformation
Regulatory Spotlight for Biotech: On the Horizon for CBER

Share This Article